SARS-CoV-2 rapid antigen testing of symptomatic and asymptomatic individuals on the University of Arizona campus
Name:
biomedicines-09-00539-v3.pdf
Size:
382.6Kb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Biorepository, College of Medicine-Tucson, University of Arizona Health Sciences, University of ArizonaCollege of Medicine-Tucson, University of Arizona Genetics Core, University of Arizona
Department of Athletic, University of Arizona
Data Science Institute, University of Arizona
Department of Surgery, College of Medicine-Tucson, University of Arizona
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine-Tucson, University of Arizona
Department of Medicine, University of Arizona-Phoenix
Department of Emergency Medicine, College of Medicine-Tucson
Department of Pathology, University of Arizona College of Medicine-Tucson, University of Arizona
Issue Date
2021Metadata
Show full item recordPublisher
MDPI AGCitation
Harris, D. T., Badowski, M., Jernigan, B., Sprissler, R., Edwards, T., Cohen, R., Paul, S., Merchant, N., Weinkauf, C. C., Bime, C., Erickson, H. E., Bixby, B., Parthasarathy, S., Chaudhary, S., Natt, B., Cristan, E., El Aini, T., Rischard, F., Campion, J., … Dake, M. D. (2021). SARS-CoV-2 rapid antigen testing of symptomatic and asymptomatic individuals on the University of Arizona campus. Biomedicines, 9(5).Journal
BiomedicinesRights
Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
SARS-CoV-2, the cause of COVID19, has caused a pandemic that has infected more than 80 M and killed more than 1.6 M persons worldwide. In the US as of December 2020, it has infected more than 32 M people while causing more than 570,000 deaths. As the pandemic persists, there has been a public demand to reopen schools and university campuses. To consider these demands, it is necessary to rapidly identify those individuals infected with the virus and isolate them so that disease transmission can be stopped. In the present study, we examined the sensitivity of the Quidel Rapid Antigen test for use in screening both symptomatic and asymptomatic individuals at the University of Arizona from June to August 2020. A total of 885 symptomatic and 1551 asymptomatic subjects were assessed by antigen testing and real-time PCR testing. The sensitivity of the test for both symptomatic and asymptomatic persons was between 82 and 90%, with some caveats. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.Note
Open access journalISSN
2227-9059Version
Final published versionScopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).